Inactive Instrument

News Paladin Labs Inc.

Equities

PLB

CA6959421026

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Endo : Exclusive: Drugmaker Endo vying for Salix takeover	13/02/15	RE
Paladin Labs Inc. : Endo Announces Shareholder Approval of its Acquisition of Paladin Labs	26/02/14	PR
Paladin Labs Inc. : Endo Announces Early Termination of HSR Act Waiting Period and Canadian Competition Act Compliance in Connection with Its Proposed Acquisition of Paladin Labs	19/12/13	PR
Paladin Labs Inc.'s Share Price Nearly Doubles to Lead the Ubika Healthcare Growth 20 Report	14/11/13	NE
Application Software Stock Hits Another 52-Week High to Lead Smallcappower.com's Breakout Stocks to Watch	14/11/13	NE
Paladin Labs Inc. : Endo buys Canada's Paladin to counter sliding sales	05/11/13	RE
Paladin Labs Inc. : TO BE ACQUIRED BY ENDO HEALTH SOLUTIONS INC. FOR $77 PER SHARE	05/11/13	PU
Paladin Labs Inc. : Endo to Acquire Specialty Pharmaceutical Company Paladin Labs	05/11/13	PR
Paladin Labs Inc. : PALADIN LABS ANNOUNCES THE CANADIAN LAUNCH OF EMTRIX(R)	19/08/13	PU
Paladin Labs Inc. : PALADIN LABS REPORTS SECOND QUARTER 2013 RESULTS	14/08/13	PU
Paladin Labs Inc. : PALADIN ANNOUNCES PASSING OF FOUNDING CHAIRMAN, TED WISE	13/08/13	PU
Paladin Labs Inc. : PALADIN LABS TO PRESENT AT THE CANACCORD GENUITY ANNUAL GROWTH CONFERENCE	09/08/13	PU
Paladin Labs Inc. : NOTICE OF PALADIN LABS' SECOND QUARTER 2013 RESULTS CONFERENCE CALL	07/08/13	PU
Paladin Labs Inc. : ACQUIRES ALLON THERAPEUTICS INC.	16/07/13	PU
Paladin Labs Inc. : PALADIN LABS AND NUVO RESEARCH(R) ANNOUNCE COMPLETION OF THE LOAN ARRANGEMENT	10/07/13	PU
Paladin Labs Inc. : AND BIONICHE LIFE SCIENCES INC. OFFICIALLY CLOSE DEBT REFINANCING AND UROCIDIN(TM) LICENSING DEALS	05/07/13	PU
Constellation Software Inc. : TSX hits one-week high as energy, Valeant provide boost	02/07/13	RE
Paladin Labs Inc. : PALADIN LABS ACQUIRES BINOTAL(R) IN LATIN AMERICA FROM BAYER	02/07/13	PU
Paladin Labs Inc. : PALADIN RECEIVES PRIORITY REVIEW STATUS FROM FDA FOR IMPAVIDO(R) NDA SUBMISSION	19/06/13	PU
Paladin Labs Inc. : NUVO RESEARCH(R) AND PALADIN LABS ANNOUNCE AMENDMENT TO MAY 2012 LOAN ARRANGEMENT	17/06/13	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Paladin Labs Inc.

Equities

PLB

CA6959421026

Summary

Filters